Wille AG
Investor profile
Wille AG has backed 3 European tech companies across 3 funding rounds between 2017 and 2022, joining rounds totalling €72M. Most active in Healthtech and Media. Data as of Nov 2026.
Deals
3
distinct rounds
Companies
3
backed
Active span
2017–2022
6 yrs
Total round €
€72M
sum of rounds joined
Deals by year
distinct rounds / yearWille AG — deals by year — interactive chart.
Data table
| Wille AG — deals by year | |
|---|---|
| 2017 | 1 |
| 2021 | 1 |
| 2022 | 1 |
Top sectors
by dealsWille AG — top sectors — interactive chart.
Data table
| Wille AG — top sectors | |
|---|---|
| Healthtech | 2 |
| Media | 1 |
Stages
by dealsWille AG — stages — interactive chart.
Data table
| Wille AG — stages | |
|---|---|
| Other | 1 |
| Seed | 1 |
| Series C | 1 |
Countries
by dealsWille AG — countries — interactive chart.
Data table
| Wille AG — countries | |
|---|---|
| Switzerland | 2 |
| Germany | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- VI Partners2
- 4BIO Capital1
- Bay City Capital1
- Brunnur Ventures1
- btov Partners1
- BVCF Management1
- Earlybird Venture Capital1
- Hyfinity Investments1
- Iduskia1
- Indiana Capital1
- Institute for Follicular Lymphoma Innovation1
- JOT-Berlin1
- Nan Fung Life Sciences1
- Novartis Venture Fund1
- Pivotal bioVenture Partners1
- Pureos Bioventures1
- Redalpine1
- Schroders Capital1
- Silfurberg1
- Tekla Capital Management1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Oculis | Switzerland | 1 | €47M |
| Araris Biotech | Switzerland | 1 | €24M |
| Labiotech | Germany | 1 | €0 |